Skip to content

Prof Jim Walsh

Professor Walsh is one of Ireland’s most experienced diagnostics entrepreneurs and now holds the post of Bio-Innovator in Residence with Dublin City University.

He is currently executive director and CSO of Trinity Biotech Plc, (NASDAQ: TRIB) an Irish Diagnostics company and executive chairman of Biosensia Ltd., an Irish Point of Care Diagnostics Company.  He is also an investor in and director of a number of early stage Diagnostic companies, including Enzolve Technologies Ltd. (Paediatric testing), Epona Biotech (Animal Haematology), Crescent Diagnostics Ltd., (Bone Health).

Previously Prof. Walsh was Executive Chairman of GenCell Biosystems Ltd., acquired by Becton Dickenson in 2014 and CEO of Stokes Bio Ltd., acquired by Life Technologies in 2010, non-executive director at PuriCore Plc. (LSE: PURI) and Managing Director of Cambridge Diagnostics Ltd. a wholly owned subsidiary of Alere Inc.

Prof. Walsh bring a wealth of commercial and industry expertise to the company.

Posted in